Our Company
BliitzPharma is a pioneering force in the pharmaceutical industry, providing high-quality Active Pharmaceutical Ingredients (APIs) and exclusive licensing opportunities for blockbuster pharmaceutical products. With a global reach and a commitment to regulatory excellence, we help local pharmaceutical companies succeed in competitive markets worldwide.
Bliitz Model Advantages
Partners
Key Services
API
Manufacturing:
FDA-inspected facilities, solid and soft gels, injectables, and liquids production capacity.
Learn more
Pharmaceutical
Licensing
24 blockbuster product licensing program with country exclusivity. Explore licensing opportunities
(link a la página de licencias)
Global
Reach
Great presence across various regions (North America, South America, Europe, Asia, Africa)
View our global impact
Overview of Licensing Program
24 Blockbuster Products:
Off-patent or near patent expiration.
Exclusivity:
Country exclusivity package for local companies.
Timeframe:
Five-year licensing program.
Market Reach
Regulatory Markets: Products will enter all major regulatory markets.
Global Opportunity: Expanding access to high-demand medications in various territories.
Licensing Markets
Cost Advantage
Development Costs: Licensee cost is less than one-third of the product development expenses.
Affordable Licensing: Streamlined for local companies to enter the market competitively.
Expertise and Reliability
24 Blockbuster Products:
Proven track record in navigating complex regulatory environments.
Patent & Sourcing:
Expertise in managing patent life cycles and sourcing high-quality materials.
Seamless Process:
Comprehensive support throughout the licensing process, ensuring peace of mind.
We are your Business Partner Development
Strategic Partner:
We don’t just provide licenses—we become your partner in growth.
Market Entry Support:
Offering expertise in product launch, regulatory compliance, and competitive positioning.
Long-Term Success:
Dedicated to building and expanding your market presence through continuous collaboration.
Licensing Process
Selection of licensors:
Local Pharma companies, instead of big worldwide generics
Licensing by country or by regions:
• Depending on the volumes
• Open to companies that want to bid for a region
Benefits:
• First to market in many of the products
• No risk in development process
• Investment a third of what it will cost to develop
• Pricing structure better that own manufacturing
Contact Us
Leaders in Global API Manufacturing and Pharmaceutical Licensing
MiAddvantage